Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Hongmei Dai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1641-6567; OpenAlex author ID A5103117581. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper

Papers 3

  1. Interleukin-17 activates and synergizes with the notch signaling pathway in the progression of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2021.03.003↗
  2. [The effect of para-aortic lymph node metastasis on the resectability of pancreatic cancer]. Co-author DOI 10.3760/cma.j.issn.0529-5815.2019.01.014↗
  3. Catechol-O-methyltransferase, a new target for pancreatic cancer therapy. Co-author DOI 10.1111/cas.12648↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wenming Wu · 3 shared papers, 2015–2021 · strength 0.29
  2. Yupei Zhao · 3 shared papers, 2015–2021 · strength 0.29
  3. Wenze Wang · 2 shared papers, 2015–2021 · strength 0.16
  4. Xianze Wang · 1 shared paper, 2021 · strength 0.11
  5. Hao Chen · 1 shared paper, 2021 · strength 0.11
  6. Junya Peng · 1 shared paper, 2021 · strength 0.11
  7. Junliang Lu · 1 shared paper, 2021 · strength 0.11
  8. Li Zhou · 1 shared paper, 2015 · strength 0.05
  9. Jie Zhang · 1 shared paper, 2015 · strength 0.05
  10. Huanwen Wu · 1 shared paper, 2015 · strength 0.05
  11. Lei You · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.